Skip to main content

Cerner, Claritas Collaborate on Personalized Medicine Initiative

NEW YORK (GenomeWeb News) – Cerner and Claritas Genomics said today that they will partner on a personalized medicine initiative to better integrate next-generation sequencing-based diagnostics into healthcare.

Claritas will use Cerner's Millenium Helix solution — a laboratory information system designed specifically for molecular data and genetic information — and will join Cerner's Reference Lab Network so that other Reference Lab Network partners can order and obtain results from Claritas.

Claritas, a spinout of Boston Children's Hospital that was formed in February 2013, offers genetic tests for pediatric diseases, offers exome sequencing on Life Technologies' Ion Proton system, and is developing additional tests on the Proton.

Also as part of the agreement, Cerner's wholly owned subsidiary Cerner Capital has invested in Claritas, becoming a minority shareholder, and bringing Claritas' Series A financing round to a close. In addition, Clay Patterson, managing director of Cerner Capital, has joined the Claritas board of directors.

"Cerner has long focused on the power of genomics and its impact to clinical processes, and this relationship will help advance the field and define a meaningful narrative in personalized medicine between the realms of research, diagnostics, and clinical practice," Dick Flanigan, senior vice president of Cerner, said in a statement.

"One of Claritas' goals is to enable providers at any pediatric center or practice to use genomics in routine medical care," Claritas CEO Patrice Milos said in the statement. "As a leading provider of both laboratory management systems and EMR systems in the world, Cerner has decades of experience synthesizing complex medical information across organizations to inform patient care and we are extremely pleased to have them as a strategic partner."

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.